Studies related to Nausea and Pelargonium sidoides

Treatment Of Acute Bronchitis With EPs 7630: Randomized, Controlled Trial In Children And Adolescents

Effect None
Trial Design Double blind
Trial Length 1-7 Days
Number of Subjects 220
Gender Both Genders
Age Range 1-6, 7-12, 13-17
Body Types Average
Notes for this study:
Supplementation of the standard doses of EPs7630 to children under six years of age (10 drops thrice daily), above 12 (30 drops thrice daily) or between the two ages (20 drops thrice daily) for one week around meals noted significant reductions in overall symptoms with the onset of symptom reduction occurring within 3-4 days.

Efficacy And Tolerability Of EPs 7630 In Patients (aged 6-18 Years Old) With Acute Bronchitis

Effect Decrease
Trial Design Double blind
Trial Length 1-7 Days
Number of Subjects 400
Gender Both Genders
Age Range 7-12, 13-17
Body Types Average
Notes for this study:
Supplementation of 10-30mg of EPs7630 thrice daily in youth and adolescents with acute bronchitis over a week was able to reduce symptoms as assessed by the BSS in a dose-dependent manner (although all doses were more effective than placebo).